NCT00665457 2023-09-13Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryUniversity of NebraskaPhase 2 Terminated3 enrolled 6 charts
NCT00436566 2022-08-05Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By SurgeryMayo ClinicPhase 2 Completed122 enrolled 22 charts